Signum Biosciences' Grant - II Round

Signum Biosciences raised a round of funding on September 08, 2006. Investors include New Jersey Commission on Science & Technology.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Grant - II Round: